Cargando…
Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells
Hepatocellular carcinoma (HCC) is one of the most serious cancers, with rapid progression and high mortality. However, chemotherapy of HCC is hindered by multi-drug resistance (MDR). It is urgent, therefore, to explore new approaches for overcoming MDR of HCC cells. Ubenimex, an inhibitor of CD13, h...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641159/ https://www.ncbi.nlm.nih.gov/pubmed/29069816 http://dx.doi.org/10.18632/oncotarget.20194 |